Khairy to seek EU explanation over recognising certain AZ vaccines

Khairy to seek EU explanation over recognising certain AZ vaccines

The minister says if a vaccine is recognised by WHO, other countries must do the same.

A news report claimed Malaysians who received the AstraZeneca vaccine may not be able to travel freely within Europe because the European Union only recognises vaccines approved by the European Medicines Agency.
PETALING JAYA:
Khairy Jamaluddin said he will seek further explanation from the European Union on recognising certain AstraZeneca Covid-19 vaccines which could restrict travel for Malaysians within Europe.

He went on to express hope there would be no discrimination in terms of where the vaccine was produced, saying the factories producing AstraZeneca vaccines worldwide were using the same formula.

“All the vaccines are the same. To exclude some of them is unfair.”

Khairy said the matter of vaccine recognition was something that needed to be discussed thoroughly by the international community.

The minister in charge of the national vaccination programme said he would discuss the matter with EU’s representative in Malaysia.

“Our stance has always been that if it is recognised by WHO, then we will appeal to other countries to do the same,” he told reporters, referring to the World Health Organization.

Khairy was asked to comment on a report that Malaysians who received the AstraZeneca vaccine may not be able to travel freely within Europe because the European Union only recognises vaccines approved by the European Medicines Agency (EMA).

According to a report by CodeBlue, the approval for Covid-19 vaccines does not cover the AstraZeneca vaccine made by South Korea’s SK Bioscience or Thailand’s Siam Bioscience. Japan’s labs are also not on EMA’s approval list for the vaccine.

CLICK HERE FOR THE LATEST DATA ON THE COVID-19 SITUATION IN MALAYSIA

We are live on Telegram, subscribe here for breaking news and the latest announcements.

Stay current - Follow FMT on WhatsApp, Google news and Telegram

Subscribe to our newsletter and get news delivered to your mailbox.